Lemonade (LMND) Earnings Date & Reports

Key Takeaways

• Lemonade reports Q2 2026 results on Wednesday, July 29, before market open; consensus EPS (earnings per share) estimate stands at -$0.57 with revenue near $291 million.
• Revenue is expected to grow roughly 77% year-over-year, building on ten consecutive quarters of accelerating IFP (in-force premium) growth.
• The company guided Q2 revenue between $287 million and $290 million, placing consensus slightly above the high end of that range.
• Profitability remains the central narrative: management expects to reach positive adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) by Q4 2026.
• Analyst sentiment is cautious but divided, with a consensus Hold rating and a price target range spanning from $37 to $92.
• Post-earnings stock reactions have been volatile historically, with recent quarters producing double-digit percentage moves in both directions.

Earnings Context and Why It Matters

Lemonade's Q2 2026 report carries heightened importance for investors tracking the company's journey toward profitability. The AI-driven insurer has posted ten straight quarters of accelerating IFP growth, most recently delivering a 32% year-over-year increase to $1.33 billion in Q1. Revenue surged 71% in that same period, and gross profit jumped 159%. With the stock trading around $60 — down approximately 40% from its 52-week high of $99.90 — this earnings release will test whether Lemonade can sustain its top-line momentum while demonstrating credible progress on narrowing losses. As a high-beta, growth-stage insurance disruptor operating across renters, homeowners, auto, pet, and life segments, each quarterly update carries outsized weight for both retail and institutional investors evaluating the long-term business model.

Earnings Expectations

According to data compiled from 11 analysts, the consensus EPS estimate for Q2 2026 is approximately -$0.57, which would mark a year-over-year improvement from -$0.60 reported in Q2 2025. Revenue expectations center around $291 million, representing approximately 77% growth compared to the $164.1 million recorded in the same quarter last year. The company's own revenue guidance, issued alongside Q1 results in late April, called for a range of $287 million to $290 million — meaning consensus sits modestly above the high end of management's forecast.

Beyond the headline numbers, investors will closely scrutinize several operating metrics. IFP growth will remain a key barometer of demand across Lemonade's multi-line insurance platform. The gross loss ratio, which measures claims paid as a percentage of premiums earned, will signal underwriting discipline — a metric that has shown improvement in recent quarters. Customer count, which reached 3.14 million in Q1 (up 23% year-over-year), and premium per customer trends will further inform the growth narrative. On the profitability front, adjusted EBITDA and free cash flow will be watched closely as the company aims for positive adjusted EBITDA by Q4 2026.

AI Screener

For investors seeking to identify earnings-season opportunities beyond individual tickers like LMND, Tickeron's AI Screener offers a powerful AI-driven discovery platform that scans thousands of stocks and ETFs using customizable filters spanning technical patterns, fundamental metrics, volatility profiles, and proprietary AI-generated signals. Users can narrow the universe by industry, market capitalization, price patterns, and performance benchmarks to surface trade ideas, breakout candidates, and emerging trends far more efficiently than manual screening. Whether monitoring earnings-driven momentum or scanning for pre-breakout setups across the insurance technology sector, the AI Screener helps streamline the research process for both active traders and long-term investors.

Market Reaction and Investor Sentiment

Lemonade shares enter the Q2 print under a cloud of mixed sentiment. The stock has declined roughly 10% over the past week and sits below both its 50-day and 200-day moving averages as of late July. Analysts remain divided: of 11 analysts tracked by S&P Global, two rate the stock Strong Buy, one rates it Buy, five rate it Hold, one rates it Sell, and two rate it Strong Sell. The average 12-month price target is approximately $64, implying modest upside from current levels.

Morgan Stanley downgraded Lemonade from Overweight to Equal-Weight on July 8, maintaining a $75 price target but flagging that the stock required a new catalyst to justify its valuation after a roughly 50% rally in preceding weeks. Separately, Piper Sandler raised its price target to $75 on July 15 while keeping a Neutral rating. Historical post-earnings stock reactions underscore the binary risk: Q1 2026 results saw a roughly 15% one-day decline despite a beat on both EPS and revenue, while Q3 2025 and Q2 2025 saw one-day gains of approximately 31% and 26%, respectively. The implied volatility heading into this report suggests traders are bracing for another significant move.

Forward Outlook and Key Factors to Monitor

Looking beyond the Q2 print, several interconnected themes will shape the investment narrative for Lemonade through the remainder of 2026. The most closely watched milestone is the company's target of achieving positive adjusted EBITDA by the fourth quarter. Any commentary on the earnings call that signals confidence — or caution — around that timeline will likely drive significant post-report price action.

The auto insurance market environment represents another critical variable. Morgan Stanley has flagged a "softening" auto insurance market as a potential headwind, and investors will listen for how Lemonade's leadership characterizes pricing conditions and competitive dynamics in its car insurance book. A recently enhanced reinsurance program could serve as a tailwind by reducing risk exposure and improving capital efficiency, but its impact will need to be demonstrated over multiple quarters.

Cost discipline remains essential. Lemonade has shown progress on adjusted free cash flow, which reached $17 million in Q1 2026. Sustaining or improving that trajectory while continuing to invest in customer acquisition and product expansion — including its growing European footprint across Germany, the Netherlands, France, and the UK — will be a delicate balancing act. Finally, the company's Investor Day scheduled for November 17, 2026, in New York City may serve as a catalyst for updated long-term targets and strategic clarity later in the year.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations